DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1036401
Abstract: Osteosarcoma (OS) is a primary malignant tumor of the bone characterized by poor prognosis due to chemotherapy resistance and high recurrence rates. DJ-1 (PARK7) is known as an oncogene and its abnormal expression is related… read more here.
Keywords: progression; promotes osteosarcoma; cdk4 e2f1; activating cdk4 ... See more keywords